Anzeige
Mehr »
Login
Sonntag, 24.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Analysten heben Kursziel massiv an! Chance auf über +140%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W8DY ISIN: US83587F2020 Ticker-Symbol: 8STN 
Tradegate
22.10.21
19:11 Uhr
5,452 Euro
-0,196
-3,47 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SORRENTO THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SORRENTO THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,4945,52818:57
5,4295,65922.10.

Aktuelle News zur SORRENTO THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSorrento Therapeutics rapid COVID test receives CE Mark5
MiSorrento Therapeutics, Inc.: Sorrento Announces That COVISTIX (COVID-19 Virus Rapid Antigen Detection Test) Has Received a CE Mark and Registration of ...5
SORRENTO THERAPEUTICS Aktie jetzt für 0€ handeln
13.10.Sorrento Therapeutics gets FDA greenlight for ESG-401 cancer trials7
13.10.Sorrento Therapeutics, Inc.: Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2 Antibody Drug Conjugate (TROP-2 ADC) for multiple ...4
13.10.Sorrento Therapeutics, Inc.: FDA Authorizes Sorrento Phase 2 Trial of Epidural Resiniferatoxin for the Orphan Indication of Control of Intractable Cancer ...5
09.10.Sorrento Therapeutics: Wide Oncology Pipeline, And Watch Out For COVID Updates9
30.09.Sorrento Therapeutics, Inc. - 8-K, Current Report12
30.09.Sorrento Therapeutics, Inc. (SRNE) CEO Henry Ji Presents at Benzinga Healthcare Small Cap Conference (Transcript)5
29.09.Sorrento Therapeutics, Inc. (SRNE) CEO Henry Ji Presents at Benzinga Healthcare Small Cap Conference6
28.09.Sorrento Therapeutics, Inc.: Sorrento to Participate in the Benzinga Healthcare Small Cap Conference on September 30th3
27.09.Sorrento Therapeutics, Inc.: Dr. Henry Ji, Sorrento Chairman and CEO, to Participate in the Virtual Cantor Global Healthcare Conference on September 29th, ...5
19.09.Sorrento Therapeutics, Inc.: Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus ...13
13.09.Sorrento Therapeutics, Inc. - 8-K, Current Report6
13.09.Sorrento Therapeutics, Inc.: Dr. Henry Ji, Sorrento Chairman and CEO, to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September ...3
02.09.Sorrento Therapeutics, Inc.: Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute ...11
31.08.Sorrento pitches lymphatic delivery for COVID-19 vaccine dose sparing13
26.08.Why Shares of Sorrento Therapeutics Jumped This Week14
26.08.Sorrento Therapeutics, Inc.: Sorrento Exercises Exclusive Option Agreement With Texas A&M University for MPRO Inhibitors Against Sars-Cov-2 and all Variants ...8
26.08.Sorrento Therapeutics, Inc.: Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device8
24.08.Sorrento Therapeutics enters option agreement for SARS-CoV-2 main protease IP11
Seite:  Weiter >>
73 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2